Alberto Cauli Selected Research

Alberto Cauli Research Topics

Disease

21	Psoriatic Arthritis 03/2024 - 05/2007
18	Ankylosing Spondylitis 08/2023 - 05/2003
17	Rheumatoid Arthritis 04/2024 - 11/2015
12	Arthritis (Polyarthritis) 04/2024 - 05/2007
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 07/2016
8	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2007
4	Rheumatic Diseases (Rheumatism) 11/2023 - 01/2021
4	Necrosis 08/2023 - 01/2016
3	Central Nervous System Lupus Vasculitis 04/2024 - 01/2017
3	Axial Spondyloarthritis 03/2024 - 07/2014
3	Inflammation (Inflammations) 01/2021 - 01/2015
3	Malaria 01/2019 - 05/2008
2	Atherosclerosis 01/2021 - 01/2018
2	Virus Diseases (Viral Diseases) 11/2019 - 09/2016
2	Spondylitis 11/2017 - 11/2012
2	Autoimmune Diseases (Autoimmune Disease) 03/2009 - 05/2008
2	Spondylarthropathies 03/2009 - 10/2005
1	Cognitive Dysfunction 11/2023
1	Skin Manifestations 04/2023
1	Sacroiliitis 01/2023
1	Low Back Pain (Lumbago) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022
1	Pericarditis 01/2022
1	Serositis 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Heart Diseases (Heart Disease) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Disease Progression 01/2021
1	Behcet Syndrome (Behcet's Syndrome) 11/2020
1	Vasculitis (Vasculitides) 01/2020
1	Transverse Myelitis (Necrotizing Myelitis) 03/2017

Drug/Important Bio-Agent (IBA)

10	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2019 - 05/2003
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
5	C-Reactive ProteinIBA 10/2022 - 01/2021
5	Prostaglandins AIBA 12/2020 - 05/2011
4	Etanercept (Enbrel)FDA Link 11/2023 - 01/2011
4	HLA-B Antigens (HLA-B)IBA 08/2023 - 08/2007
4	Tumor Necrosis Factor InhibitorsIBA 06/2023 - 01/2016
4	GlucocorticoidsIBA 04/2023 - 01/2021
3	golimumab FDA Link 03/2024 - 01/2021
3	Antirheumatic Agents (DMARD)IBA 01/2024 - 06/2020
3	Rituximab (Mabthera)FDA Link 11/2023 - 01/2017
3	Methotrexate (Mexate)FDA LinkGeneric 04/2021 - 11/2015
3	AntigensIBA 12/2019 - 03/2009
3	HLA-B*27:05 antigenIBA 09/2016 - 03/2009
3	HLA-B*27:09 antigenIBA 01/2012 - 05/2003
2	AutoantibodiesIBA 11/2023 - 01/2023
2	tocilizumab (atlizumab)FDA Link 11/2023 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2023 - 11/2019
2	SteroidsIBA 01/2022 - 01/2021
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022 - 05/2007
2	apremilastIBA 01/2022 - 01/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2019
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2021 - 11/2015
2	EpitopesIBA 11/2019 - 09/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 07/2014
2	Interleukin-23 (Interleukin 23)IBA 01/2015 - 07/2012
1	GLPG0634IBA 04/2024
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	N-Methylaspartate (NMDA)IBA 11/2023
1	Monoclonal AntibodiesIBA 08/2023
1	Interleukin-12 (IL 12)IBA 08/2023
1	belimumabIBA 04/2023
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2023
1	mesoglycanIBA 01/2022
1	CT-P13IBA 01/2022
1	Infliximab (Remicade)FDA Link 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	InterleukinsIBA 01/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	RoflumilastIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Immunoglobulin D (IgD)IBA 03/2021
1	Synthetic DrugsIBA 03/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	HDL CholesterolIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	secukinumabIBA 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 12/2020
1	AminopeptidasesIBA 12/2019
1	Intergenic DNA (Junk DNA)IBA 12/2019
1	CytokinesIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	AntibodiesIBA 11/2017
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 03/2017

Therapy/Procedure

8	Therapeutics 11/2023 - 01/2016
3	Biological Therapy 11/2023 - 05/2011
1	Precision Medicine 04/2021